Raghuram Selvaraju's
Stock Forecasts

Raghuram Selvaraju win rate

3.23%

1/31 win trades

Raghuram Selvaraju is a Wall Street stock analyst with a 3.23% win rate, who was right in predicting 1 out of 31 price targets. Most frequently covered stocks by this analyst are VRNA, FENC, SLNO and BCPC. He has published 0 price targets in the last month and 7 last year.

Price targets by Raghuram Selvaraju

Company name & ticker Publish date Price target Price when posted Source Historical targets
SLNO logo
Soleno Therapeutics, Inc.
SLNO
9 months ago $70 4.77% upside $50.91 StreetInsider Previous targets (0)
BCPC logo
Balchem Corporation
BCPC
10 months ago $190 17.90% upside $175.31 StreetInsider Previous targets (0)
VRNA logo
Verona Pharma plc
VRNA
10 months ago $42 -60.12% downside $38.39 StreetInsider
RVMD logo
Revolution Medicines, Inc.
RVMD
10 months ago $62 69.67% upside $55.87 StreetInsider Previous targets (0)
ANVS logo
Annovis Bio, Inc.
ANVS
11 months ago $30 1036.36% upside $8.82 StreetInsider Previous targets (0)
ADMA logo
ADMA Biologics, Inc.
ADMA
11 months ago $18 2.97% upside $17.15 StreetInsider Previous targets (0)
RYTM logo
Rhythm Pharmaceuticals, Inc.
RYTM
12 months ago $64 -34.19% downside $53.17 TheFly Previous targets (0)
AXSM logo
Axsome Therapeutics, Inc.
AXSM
about 1 year ago $180 60.71% upside $83.21 TheFly Previous targets (0)
OVID logo
Ovid Therapeutics Inc.
OVID
about 1 year ago $3 222.23% upside $0.86 StreetInsider Previous targets (0)
MLTX logo
MoonLake Immunotherapeutics
MLTX
about 1 year ago $100 89.89% upside $43.97 StreetInsider Previous targets (0)
GMAB logo
Genmab A/S
GMAB
about 1 year ago $50 109.90% upside $25.71 StreetInsider Previous targets (0)
BNTX logo
BioNTech SE
BNTX
about 1 year ago $113 0.53% upside $82.52 StreetInsider Previous targets (0)
TRDA logo
Entrada Therapeutics, Inc.
TRDA
about 1 year ago $18 227.27% upside $14.24 TheFly Previous targets (0)
URGN logo
UroGen Pharma Ltd.
URGN
about 1 year ago $60 216.62% upside $17.5 TheFly Previous targets (0)
RKDA logo
Arcadia Biosciences, Inc.
RKDA
over 1 year ago $6 34.52% upside $2.78 TheFly Previous targets (0)
BBIO logo
BridgeBio Pharma, Inc.
BBIO
over 1 year ago $43 -13.56% downside $30.09 StreetInsider Previous targets (0)
FENC logo
Fennec Pharmaceuticals Inc.
FENC
over 1 year ago $15 86.10% upside $7.03 StreetInsider
SRTS logo
Sensus Healthcare, Inc.
SRTS
over 1 year ago $10 212.5% upside $5.56 StreetInsider Previous targets (0)
BWAY logo
BrainsWay Ltd.
BWAY
over 1 year ago $15 4.74% upside $5.7 StreetInsider Previous targets (0)
BTAI logo
BioXcel Therapeutics, Inc.
BTAI
over 1 year ago $10 96.49% upside $2.9 StreetInsider Previous targets (0)
ONCT logo
Oncternal Therapeutics, Inc.
ONCT
over 1 year ago $28 N/A downside $9.4 StreetInsider Previous targets (0)
AQST logo
Aquestive Therapeutics, Inc.
AQST
over 1 year ago $9 131.95% upside $5.51 StreetInsider Previous targets (0)
BDTX logo
Black Diamond Therapeutics, Inc.
BDTX
over 1 year ago $12 354.54% upside $4.7 StreetInsider Previous targets (0)
KRTX logo
Karuna Therapeutics, Inc.
KRTX
over 1 year ago $330 N/A downside $317 Benzinga Previous targets (0)

Other analysts covering same stocks

Andrew Ang
UBS
100%
win rate
Covering:
Covering:
Covering:
Covering:
Covering:
Covering: